Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes.
Journal Information
Full Title: Ther Adv Psychopharmacol
Abbreviation: Ther Adv Psychopharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement: All authors received non-financial support from Janssen during the conduct of the study. RE has participated in advisory boards and received honoraria from Janssen, Lundbeck, Servier and Otsuka. He has also received research funding from Janssen and Lundbeck. P-ML reports personal fees from Janssen, Eisai, Lundbeck, Otsuka, and Bouchara-Recordatti. PB, AW, SG, MM and KP are employees of Janssen."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This analysis was sponsored by Janssen. Medical writing and editorial support were funded by Janssen."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025